Host: Darryl S. Chutka, M.D. [@chutkaMD]

Guest: Alan H. Bryce, M.D.

Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early, and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D., from the Division of Hematology and Oncology at the Mayo Clinic.

This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.